The impact of perinatal probiotic intervention on gut microbiota: Double-blind placebo-controlled trials in Finland and Germany

Anaerobe

Volumn 18, Issue 1, 2012, Pages 7-13

  Grześkowiak, Łukasz ^a   Grönlund, Minna Maija ^b   Beckmann, Christina ^c   Salminen, Seppo ^a   von Berg, Andrea ^c   Isolauri, Erika ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c MARIEN HOSPITAL WESEL   (Germany)

Author keywords

Breastfeeding; Formula feeding; Gut microbiota; Infant; Probiotic

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

AKKERMANSIA; ARTICLE; BACTERIAL COUNT; BACTEROIDES; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; BREAST FEEDING; CLOSTRIDIUM HISTOLYTICUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS; ETHNIC GROUP; FEMALE; FINLAND; FINNISH; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GERMAN; GERMANY; HUMAN; INFANT; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; MICROBIAL DIVERSITY; NONHUMAN; PERINATAL CARE; PREVOTELLA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WEANING;

BREAST FEEDING; DOUBLE-BLIND METHOD; FECES; FINLAND; GERMANY; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; INTESTINES; METAGENOME; PROBIOTICS;

AKKERMANSIA; BACTEROIDES; BIFIDOBACTERIUM LONGUM; CLOSTRIDIUM HISTOLYTICUM; ENTEROCOCCUS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; PREVOTELLA;

EID: 84856722514     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.09.006     Document Type: Article

References (41)

1. Mackie R.I., Sghir A., Gaskins H.R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999, 69:1035-1045.
2. Favier C.F., Vaughan E.E., de Vos W.M., Akkermans A.D.L. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002, 68:219-226.
3. Adlerberth I., Wold A.E. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009, 98:229-238.
4. Grönlund M.M., Lehtonen O.P., Eerola E., Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. JPediatr Gastroenterol Nutr 1999, 28:19-25.
5. Benno Y., Mitsuoka T. Development of intestinal microflora in humans and animals. Bifidobateria Microflora 1986, 5:13-25.
6. Harmsen H.J.M., Wildeboer-Veloo A.C.M., Wagendorp A.A., Kalliomäki M., Collado M.C., Salminen S., et al. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008, 87:534-538.
7. Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 1999, 65:4506-4512.
8. He F., Ouwehand A.C., Isolauri E., Hashimoto H., Benno Y., Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001, 30:43-47.
9. Rinne M., Gueimonde M., Kalliomäki M., Hoppu U., Salminen S.J., Isolauri E. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol 2005, 43:59-65.
10. Grönlund M.M., Gueimonde M., Laitinen K., Kociubinski G., Grönroos T., Salminen S., et al. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007, 37:1764-1772.
11. Ouwehand A.C., Isolauri E., He F., Hashimoto H., Benno Y., Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. JAllergy Clin Immunol 2001, 108:144-145.
12. Juntunen M., Kirjavainen P., Ouwehand A.C., Salminen S.J., Isolauri E. Gut microflora changes and probiotics in children in day care centers. Biosci Microflora 2003, 22:99-107.
13. Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008, 88:894-899.
14. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 2001, 357:1076-1079.
15. FAO/WHO. Guidelines for the evaluation of probiotics in food. Food Agric Organ United Nation World Health Organ. Working Group Report 2002.
16. Isolauri E., Sütas Y., Kankaanpää P., Arvilommi H., Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001, 73:444-450.
17. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., van der Heide S., Jansen D.F., Hoijer M.A., et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006, 36:899-906.
18. Kopp M.V., Hennemuth I., Heinzmann A., Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008, 121:850-856.
19. Matsuki T., Watanabe K., Fujimoto J., Takada T., Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004, 70:7220-7228.
20. Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., et al. Stobberingh EE factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
21. Kalliomäki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008, 87:534-538.
22. Amann R.I., Binder B.J., Olson R.J., Chisholm S.W., Devereux R., Stahl D.A. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990, 56:1919-1925.
23. Langendijk P.S., Schut F., Jansen G.J., Raangs G.C., Kamphuis G.R., Wilkinson M.H., et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995, 61:3069-3075.
24. Manz W., Amann R., Ludwig W., Vancanneyt M., Schleifer K.H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-Bacteroides in the natural environment. Microbiology 1996, 142:1097-1106.
25. Franks A.H., Harmsen H.J.M., Raangs G.C., Jansen G.J., Schut F., Welling G.W. Variation of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998, 64:3336-3345.
26. Rigottier-Gois L., Le Bourhis A.G., Gramet G., Rochet V., Doré J. Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol Ecol 2003, 43:237-245.
27. Gueimonde M., Tölkkö S., Korpimäki T., Salminen S. New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Appl Environ Microbiol 2004, 70:4165-4169.
28. Rinne M., Kalliomäki M., Salminen S., Isolauri E. Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. JPediatr Gastroenterol Nutr 2006, 43:200-205.
29. Sepp E., Julge K., Vasar M., Naaber P., Björksten B., Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997, 86:956-961.
30. Bjorksten B., Naaber P., Sepp E., Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999, 29:342-346.
31. Fallani M., Young D., Scott J., Norin E., Amarri S., Adam R., et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. JPediatr Gastroenterol Nutr 2010, 51:77-84.
32. Collado M.C., Derrien M., Isolauri E., de Vos W.M., Salminen S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 2007, 73:7767-7770.
33. Derrien M., Collado M.C., Ben-Amor K., Salminen S., de Vos W.M. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol 2008, 74:1646-1648.
34. Derrien M., Vaughan E.E., Plugge C.M., de Vos W.M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 2004, 54:1469-1476.
35. Derrien M. Mucin utilisation and host interactions of the novel intestinal microbe Akkermansia muciniphila. 2007;pp. 1-174.
36. Wexler H.M. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007, 20:593-621.
37. Stark P.L., Lee A. Clostridia isolated from the feces of infants during the first year of life. JPediatr 1982, 100:362-365.
38. Tonooka T., Sakata S., Kitahara M., Hanai M., Ishizeki S., Takada M., et al. Detection and quantification of four species of the genus Clostridium in infant feces. Microbiol Immunol 2005, 49:987-992.
39. Lahtinen S.J., Boyle R.J., Kivivuori S., Oppedisano F., Smith K.R., Robins-Browne R., et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. JAllergy Clin Immunol 2009, 123:499-501.
40. Gueimonde M., Sakata S., Kalliomäki M., Isolauri E., Benno Y., Salminen S. Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. JPediatr Gastroenterol Nutr 2006, 42:166-170.
41. Lin H.C., Hsu C.H., Chen H.L., Chung M.Y., Hsu J.F., Lien R.I., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008, 122:693-700.